跳至主要内容
临床试验/EUCTR2006-002682-40-DK
EUCTR2006-002682-40-DK进行中(未招募)1 期

Augmenting clozapine with sertindole - A double-blinded randomized placebo study (SERCLOZ) - SERCLOZ

Aalborg Psychiatric Hospital, Research Unit0 个研究点目标入组 50 人开始时间: 2006年8月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Both sexes, 18-65 years.
  • Minimum treatment with clozapine for six months
  • Fixed dosage dosage of clozapine and other psychotropics last month prior inclusion except for benzodiazepines and anticholinergics.
  • No other antipsychotic during the study than sertindole and clozapine
  • PANSS score more than 65
  • Informed consent given
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Clinical important cardiovascular disease
  • Prescribing other antipsychotics than clozapine
  • Compulsory measures
  • QT prolongation to more than 500 ms.
  • Concomitant potent CYP2D6 inhibitors
  • ICD-10 Major depression
  • Disruption of clozapine bloodsamples
  • Disruption of SPC of Serdolect and clozapine

研究者

发起方
Aalborg Psychiatric Hospital, Research Unit

相似试验